Investigation of the Efficacy of an Administration Plan for Tazobactam/Piperacillin (TAZ/PIPC) and the Incidence of Kidney and Hepatic Disorders-Reference-Cited by-同舟云学术

Investigation of the Efficacy of an Administration Plan for Tazobactam/Piperacillin (TAZ/PIPC) and the Incidence of Kidney and Hepatic Disorders

Published:2017-10-01 Issue:10 Volume:137 Page:1277-1284
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

Senba Mina¹,Isami Keisuke¹,Yamashita Katsuya¹,Tsumagari Kyouichi¹,Yamashina Takuya²,Sasaki Eiji²,Tsuruta Minako²,Miyoshi Takanori²,Kawamata Yosei²,Kozono Aki¹

Affiliation:

1. Department of Pharmacy, National Hospital Organization Kumamoto Saishunso National Hospital

2. Department of Pharmacy, National Hospital Organization Beppu Medical Center

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/137/10/137_17-00016/_pdf

Reference20 articles.

1. 1) Perry C. M., Markham A., Drugs, 57, 805-843 (1999).

2. 2) Nishida K., Higashitani F., Hyodo A., Chemotherapy, 43, 171-178 (1997).

3. 3) Craig W. A., Clin. Infect. Dis., 26, 1-12 (1998).

4. 4) Drusano G. L., Craig W. A., J. Chemother., 9, 38-44 (1997).

5. 5) Ambrose P. G., Bhavnani S. M., Jones R. N., Antimicrob. Agents Chemother, 47, 1643-1646 (2003).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study;Scientific Reports;2024-08-06

2. Investigation of tazobactam/piperacillin– or meropenem–induced liver injury based on retrospective observational study and the FDA Adverse Event Reporting System;2023-11-17